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Rabies is a fatal, preventable zoonosis, but it is not
effectively controlled throughout much of the developing
world. The impetus for control is hampered by a lack of
awareness of its true impact. We estimate a disability-
adjusted life year (DALY) score for rabies to quantify the
disease impact relative to other diseases to set priorities for
public health interventions.
R
abies is a fatal disease that is considered a reemerging
zoonosis throughout much of the world (1,2). Rabies
satisfies all the World Health Organization (WHO) criteria
for diseases that are a priority for control (3) and, unlike
many other emerging zoonoses (such as West Nile virus),
safe and effective animal and human vaccines are widely
available for its prevention and control. Despite this, rabies
remains a neglected disease that is poorly controlled
throughout much of the developing world, particularly
Africa and Asia, where most human rabies deaths occur
(3,4). A major factor in the failure of rabies control is the
low level of political commitment, partly arising from a
lack of quantitative data on the true public health impact of
the disease (3) and the cost-effectiveness and cost benefits
of controlling it (5). 
The disability-adjusted life year (DALY) is a standard-
ized, comparative measure of disease impact developed to
assess the relative impact of different diseases across dif-
ferent settings and at different stages of economic and pub-
lic health development (6). The DALY is a combination of
the years of life lost (YLL) due to premature death and the
years of life lived with a disability (YLD). DALYs have
been used to organize disease control in the health sector
(7) because interventions can be prioritized on the basis of
their impact in reducing disease and on the cost-effective-
ness of the intervention. Most emerging human diseases
are zoonotic (2); while DALYs have been estimated for
some of these, such as leishmaniasis and trypanosomiasis,
a DALYscore has never been determined for rabies, which
has failed to be considered in any of the annual global dis-
ease burden estimates made by WHO (8).
Country-Level Estimates
A DALY estimate, which can be used to rank diseases
globally, can also be used to prioritize health interventions
at a country level. As a result of widespread problems of
data quality and underreporting of rabies, a new approach
has recently been adopted in Tanzania to estimate human
rabies deaths by using a decision-tree method based on the
incidence of human dog-bite injuries. Such bites are
reported routinely and more reliably than rabies cases
themselves (9). Age-specific human rabies incidence fig-
ures calculated from detailed data collected in the Mara
Region (9), northern Tanzania, were extrapolated to pro-
vide a country-level rabies DALY estimate of 42,669 for
all of Tanzania in 2000 (Table 1). 
This example demonstrates how a country-specific
mortality and DALY estimate can be calculated by using
quality data collected from a specific study site. Indeed,
the same method used to estimate the annual number of
human rabies cases (9), and thus DALY impact, in
Tanzania may be applied across sub-Saharan Africa to esti-
mate the regional level of underreporting relative to offi-
cially reported figures. However, care needs to be taken
when extrapolating from small-scale studies to regional
and national levels. For example, in Tanzania, country-
level estimates of human rabies deaths are likely to be
affected by regional variations in rabies incidence in dif-
ferent dog populations (which are the main source of
human rabies exposures), availability of postexposure
treatment, and levels of knowledge about rabies, which
will affect the probability of seeking treatment in hospitals.
In addition, knowing the scale of DALYs lost due to a sin-
gle disease in isolation is not helpful to decision makers
prioritizing interventions with limited funds. Better coun-
try-level estimates for other diseases also need to be deter-
mined. However, this study is a first step.
Global Estimate
We calculated the global DALY for rabies based on
annual WHO estimates of 35,000 deaths (10) and using a
standard method (6) to allow comparison with the most
recent estimates (8) for the diseases identified for the
United Nations Development Program/World Bank/WHO
Special Programme for Research and Training in Tropical
Diseases, known as TDR (11). The figure of 35,000 deaths
per year may be expressed in terms of DALYs if certain
assumptions about the age and sex distribution of rabies
patients are made. Data on the age-related exposure to
rabies were obtained from Eng et al. (12), a detailed study
of human rabies in Mexico. Analysis of dog bite injuries
showed a ratio of male:female cases of 0.53:0.47. The age
distribution of persons bitten was skewed towards the
younger ages (median age 9 years, range <1–84 years) a
common pattern seen across developing country settings;
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When these age and sex distributions of patients are
used, an annual impact of 35,000 human rabies deaths
equates to approximately 1.16 million DALYs. This esti-
mated DALY impact is conservative because it considers
only the YLL component and does not takes into account
YLDs resulting from the illness associated with the trauma
of animal bites and postexposure therapy, if available. 
Atotal of 1.16 million DALYs places rabies just behind
trachoma, slightly above onchocerciasis, and well above
dengue (Table 2). This estimate shows rabies to be an
important disease in terms of DALYs if the WHO figures
reflect the true public health situation. However, unlike
other zoonoses in the DALYranking system, human rabies
is fully preventable by disease control aimed at the animal
reservoir. All 1.16 million DALYs could, in theory, be
averted through veterinary interventions.
Although the above DALY figure gives a useful indica-
tion of the global DALY for rabies, the true global inci-
dence (and hence DALY) of human rabies is difficult to
assess because rabies is often inconsistently reported. For
example, the 1996 World Survey of Rabies (10) recorded a
total of 33,212 rabies deaths worldwide (of which 30,000
were reported by India), while only 1,326 were reported in
1991 (when India reported only 34) (13). Although rabies
is known to be grossly underreported in most developing
countries, the degree of underreporting is difficult to
assess. However, recent studies from Tanzania indicate
that human rabies deaths may be up to 100 times higher
than officially reported (9), with an estimated incidence of
human rabies similar to that recorded during active surveil-
lance studies (14). More country-level estimates of under-
reporting, using methods similar to that developed for
Tanzania (9), need to be conducted to provide more reli-
able figures of the true global scale of human rabies.
However, even if the 35,000 estimated human rabies cases
were more than double the true global figure, the DALY
impact attributable to rabies would still be comparable to
that of dengue fever, which is recognized by TDR as a
major public health threat throughout the tropics.
Conclusions 
The value of providing a quantitative estimate of dis-
ease impact due to rabies, even with the inaccuracies of
existing case data, should not be underestimated. Rabies is
often perceived as a rare or insignificant disease of humans
in developing countries; this perception has been a major
factor hampering the development of disease control ini-
tiatives. Furthermore, control of rabies is often seen as the
responsibility of veterinary authorities, but demonstration
of the public health importance of rabies and the benefits
of disease control to the public health authorities (both in
terms of DALYs saved and reduced costs of postexposure
treatment) will encourage involvement of the health sector
in control efforts. Integration of medical and veterinary
sectors is likely to be crucial for effective disease control,
as shown by the success of recent rabies control programs
in Central and South America, where medical authorities
have taken a lead role in implementing mass dog vaccina-
tion programs (15).
This first estimate of a global DALY score for rabies,
together with the Tanzania-specific example, indicates that
the disease exerts a considerable public health impact,
exceeding other prominent diseases that currently achieve
a higher priority for disease control. Furthermore, the
human disease effects of rabies could be eliminated
through vaccination of animal reservoirs by using tech-
nologies and methods that are available and accessible. 
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Table 1. Estimates of the DALY impact of human rabies in 
Tanzania in 2000
a,b 
Age group (y)  Rabies cases 
0–4  10,986 
5–14  14,504 
15–44  13,876 
45–59  1,497 
60+  1,807 
All ages  42,669 
aDALY, disability-adjusted life year. 
bThe DALY estimates were based on the estimated incidence of human deaths  
for Tanzania as reported by Cleaveland et al. (9). 
Table 2. The global DALY scores for rabies and other selected 
diseases
a,b 
Disease  Total DALYs lost (x 1,000) 
Malaria  42,280 
Tuberculosis  36,040 
Lymphatic filariasis  5,644 
Leishmaniasis  2,357 
Schistosomiasis  1,760 
Trypanosomiasis  1,598 
Rabies  1,160 
Onchocerciasis  987 
Chagas  649 
Dengue  653 
Leprosy  177 
aDALY, disability-adjusted life year.  
bThe DALY score for rabies was based on official World Health Organization 
(WHO) figures (10). The other listed diseases constitute the official DALY score 
in 2001 for the priority diseases in the TDR (United Nations Development 
Program/World Bank/WHO Special Programme for Research and Training in Tropical 
Diseases) portfolio (8). Dr. Coleman is a research fellow at the London School of
Hygiene and Tropical Medicine with research interests in the epi-
demiology and control of infectious diseases in developing coun-
try settings.
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